MaxCyte Inc (NAS:MXCT)
$ 4.24 0.08 (1.92%) Market Cap: 436.74 Mil Enterprise Value: 293.28 Mil PE Ratio: 0 PB Ratio: 1.94 GF Score: 79/100

Preliminary Q3 2023 MaxCyte Inc Earnings Call Transcript

Oct 04, 2023 / 08:30PM GMT
Release Date Price: $3.27 (+9.00%)
Operator

Good day, everyone, and welcome to the MaxCyte third-quarter 2023 preliminary financial results conference call. Today's call is being recorded, and I would now like to turn the call over to Madar mid-August, Head of Investor Relations. Please go ahead, sir.

Sean Menarguez
MaxCyte, Inc. - IR

Thank you, Lisa, and good afternoon, everyone. My name is Sean Menarguez. I'm the Head of Investor Relations at MaxCyte. Thank you all for participating in today's conference call.

On the call for MaxCyte, we have Doug Doerfler, President and Chief Executive Officer; and Douglas J. Swirsky, Chief Financial Officer. During the call, management will review the preliminary third-quarter 2023 revenue results and updated full-year 2023 revenue guidance that we released at the close of the market today. After our prepared remarks, we will take questions. We plan to report our full financial results for the third quarter on November 8.

Before we begin, I need to read the following statement. Statements, comments made during this call may be forward-looking

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot